|
Whatman is to shed 235 jobs in its worldwide DNA filtration and storage techniques business, including 72 in the UK. 31-Dec-2002 Shire Pharmaceuticals has raised £45m from the sale of its four remaining over-the-counter products to Purdue Pharma. 31-Dec-2002 Acheson & Acheson is seeking permission to expand its toiletries factory near Trowbridge, with the creation of 30 jobs. 19-Dec-2002 Bespak, the manufacturer of inhalers and other drug delivery devices, is considering plans to shed jobs at its plants in King's Lynn, Milton Keynes and the US, in order to reduce annual costs by £2m. 16-Dec-2002 DuPont, the US chemicals company, is considering plans to invest in a number of unnamed high-technology companies in the UK, and is thought to be interested in spin-offs from Oxford and Cambridge universities. 16-Dec-2002 Xenova is to close some of its drug discovery operations with the loss of up to 40 Cambridge-based jobs, as part of a strategy to conserve cash and contract out all non-essential development activities. 12-Dec-2002 GlaxoSmithKline has agreed to sell its pharmaceuticals factory in Montrose to Akzo Nobel for undisclosed terms, and the workforce is expected to be cut from 700 to 500. 10-Dec-2002 The Department of Trade & Industry is to allocate a further £40m to stem cell research, as part of an increased science budget that will also fund neuroscience, machine vision and grid computing. 10-Dec-2002 Paradigm Therapeutics has raised £12m of venture capital to expand its Cambridge-based biotechnology business. 09-Dec-2002 City of Edinburgh Council is to consider plans for the development of a £200m biomedical research park next to the new Royal Infirmary, and construction is expected to start next year. 05-Dec-2002 GlaxoSmithKline is considering plans to outsource its IT systems in a £1.5bn 10-year deal. 05-Dec-2002 DuPontSA is to close one of its polyester resin plants in Wilton at the end of the year with the loss of 70 jobs, in order to concentrate production at the more modern M5 plant. 02-Dec-2002 Renovo has secured a further £21m of venture capital to fund the development of embryonic cell technology to help with the healing of wounds. 02-Dec-2002 Glasgow University is planning to build a £20m biomedical and cardiovascular research centre, and four construction companies will return tenders next month. 28-Nov-2002 Goldshield is linking up with Ideal Shopping Direct to launch Vitality TV, a new home shopping channel that will focus on nutritional and beauty treatments. 21-Nov-2002 Thornton & Ross is to expand its pharmaceutical powders business with the £0.8m acquisition of the Electrolade range from Middlesex-based Eastern Pharmaceuticals, and production will be transferred from France to its site in Huddersfield. 20-Nov-2002 Cambridge Antibody Technology is looking to make a substantial acquisition in order to increase the number of products in clinical development and speed up its path to profitability. 19-Nov-2002 Elementis is planning to close some US operations with the loss of 60 jobs, in order to make savings of £10m over two years. 18-Nov-2002 Rhodia is in discussions with industrial regeneration company Tamar about plans to convert parts of its chemical factory in Whitehaven into an industrial park. 11-Nov-2002 Wellcome Trust has won planning permission to build a £100m genetics laboratory at Hinxton near Cambridge by spring 2005, and up to 200 leading research scientists will be recruited. 08-Nov-2002 Boots is looking to reduce its cost base by £100m, which will lead to job losses in manufacturing and distribution and at its Nottingham head office. 08-Nov-2002 Regent-GM Laboratories, the North London-based generic pharmaceuticals manufacturer, is to stop manufacturing in the UK by the end of the year, but has not yet decided which country production will be moved to. 01-Nov-2002 Xcellsyz is to set up a new £1.5m headquarters for its biotechnology business in Newcastle with the creation of 20 jobs, and hopes to create up to 200 jobs over the next three years. 01-Nov-2002 Whatman is to relocate its Banbury-based micro-filtration laboratory and 40 jobs to a new £4m site on the Wildmere Road estate early next year, with the creation of 75 new jobs. 01-Nov-2002 Rhodia ChiRex is to shed 45 jobs at its pharmaceutical ingredients plant in Annan, Dumfries. 31-Oct-2002 Goldshield is considering plans to acquire the manufacturing operations of Dublin-based Miza, in order to secure the continued supply of a number of pharmaceutical products. 31-Oct-2002 Norwest Holst has won a £18m contract to build a biomedical sciences centre at Leicester University, with completion due in 2004. 24-Oct-2002 Alliance UniChem is planning to expand the 80-strong workforce at its Eldon Laboratories pharmaceuticals plant in Newcastle-upon-Tyne with 20 new staff over the next three years, having just opened a £2m extension at the site. 18-Oct-2002 Irish Fertilizer Industries has gone into liquidation with the loss of up to 620 jobs, including 200 at its Richardsons division in Belfast. 17-Oct-2002 Bayer is to close its diagnostics research and development operation in Cambridge with the loss of 30 jobs. 16-Oct-2002 John Innes Centre has submitted plans to build a £25m genomics research laboratory at its Norwich Research Park science institute. 14-Oct-2002 Dow Chemicals is to close one of its Dow AgroSciences research laboratories in King's Lynn by February, with the loss of 21 jobs. 11-Oct-2002 Northumbrian Water has won a £15m contract to clean up water from the Huntsman Polyurethanes plant on Teesside, which will involve the construction of 3km of pipelines and new processing plants at Wilton and Bran Sands. 10-Oct-2002 Powderject is to set up a direct sales force to sell its flu vaccine, with the creation of 25 jobs. 09-Oct-2002 The Medical Research Council is planning to spin-out a new company called Etiologics to commercialise the mouse genetics research taking place at Harwell, and £3.5m of venture capital funding has been secured. 07-Oct-2002 Elan has raised £239m from the sale of its Abelcet anti-fungal drug to Enzon of the US, and the deal includes a production plant in Indianapolis. 03-Oct-2002 GlaxoSmithKline is to shed 400 of the 1,000 jobs at its pharmaceuticals plant in Ulverston, Cumbria, over the next two years. 30-Sep-2002 Weston Medical, the developer of drug delivery systems, is reducing its workforce from 155 to 95 by the end of the year. 30-Sep-2002 Terra Nitrogen is to invest £11m in improvements at its ammonia plant in Billingham, in order to reduce energy usage, improve environmental performance and increase output. 27-Sep-2002 Nova Chemicals is to temporarily close its EPS facility at Carrington in Manchester in October, as part of a reorganisation of its styrenics business. 27-Sep-2002 Johnson Matthey has submitted plans to build three chemical silos and a processing chimney at Cresswell in North Staffordshire. 24-Sep-2002 AstraZeneca is to set up a £40m screening centre at its Alderley Park site in Cheshire by next year, in order to boost research into cancer, diabetes and other illnesses. 19-Sep-2002 Avidex has raised £11m of venture capital to fund the development of new drugs for cancer and arthritis. 18-Sep-2002 PPL Therapeutics is to close its stem cell division having failed to find a buyer, but still hopes to sell its xenotransplantation division by the end of the year. 17-Sep-2002 Alliance UniChem has raised £88m in a share placing to fund the expansion of its pharmaceutical wholesaling operations in Germany and to seek acquisitions in Sweden, Finland and Poland. 13-Sep-2002 Angel Biotechnology is setting up a new biopharmaceuticals business at the Nelson Industrial Estate in Cramlington at the end of October, and aims to create 85 jobs by mid-2003. 11-Sep-2002 Xenova is to raise about £10m in a rights issue to fund further research into a range of new drugs. 11-Sep-2002 Eli Lilly, the US pharmaceutical company, has awarded a £18m contract to Warings to build new office and loading facilities at Windlesham in Surrey. 11-Sep-2002 Axis-Shield is to invest £6m in the development of a new point-of-care system for on-the-spot tests to detect disease, and the manufacturing will be subcontracted. 09-Sep-2002 Alcan is to close its chemicals plant in Burntisland, Fife, with the loss of 370 jobs. 06-Sep-2002 Osmetech is planning to raise a further £5.4m in a share issue, in order to fund the development of electronic odour sensors, provide working capital and finance acquisitions. 05-Sep-2002 BOC and Air Liquide of France are to combine their industrial and medical gas operations in Japan, creating a new group called Japan Air Gases. 05-Sep-2002 Kudos Pharmaceuticals of Cambridge has raised £30m of venture capital to fund the development of anti-cancer treatments. 03-Sep-2002 GW Pharmaceuticals has raised £4.5m in a share issue to fund the development of prescription medicines from cannabis. 02-Sep-2002 Croda International has been approached by a potential management buy-out team at the Seatons chemical plant in Hull, with the aim of preventing the closure of the site and saving about 40 jobs. 30-Aug-2002 Reckitt Benckiser is considering plans to spend up to £1bn on acquisitions and new product launches in the personal hygiene market. 30-Aug-2002 GeneMedix is looking to open additional production plants in Asia and eastern Europe, as part of a strategy to double the size of its portfolio of generic drugs. 29-Aug-2002 Hunter-Fleming has raised £5m of venture capital to fund research into diseases of the central nervous system and immune deficiency. 27-Aug-2002 Scotts Company is considering plans to close its fertiliser plant near Ipswich with the loss of 70 jobs, in order to transfer production to sites in East Yorkshire and France. 27-Aug-2002 Gramos Surface Treatment and Applied Chemicals are to be merged into a single Smethwick-based metals treatment business with 90 staff, as part of a reorganisation by parent company Victoria International. 22-Aug-2002 Novartis has confirmed plans to build a major new pharmaceuticals production plant in Grimsby to manufacture ingredients for the Diovan treatment for high blood pressure, and construction is expected to start next year. 20-Aug-2002 Oxford University has secured a £6.8m grant from the Wellcome Trust to research the genetic causes of health problems, including diabetes and heart disease. 19-Aug-2002 Close Brothers Corporate Finance is being tasked to find a buyer for Enron Teesside Operations, the 465-acre site at Wilton that provides utility and support services to bulk chemical manufacturers. 06-Aug-2002 Elementis is looking to spend up to £150m on acquisitions to expand its chemicals business, and will focus on speciality chemicals for the consumer market. 01-Aug-2002 Cambridge Biotechnology has received £6m of venture capital to fund the development of new treatments for pain and obesity. 25-Jul-2002 Genetix is forming a joint venture with the Medical Research Council's Human Genome Mapping Project Resource Centre to map the proteins of the human body, with an initial budget of £2.5m. 22-Jul-2002 Harwell International Business Centre is considering plans to transform its 730-acre site near Oxford into a biotechnology park, and companies are expected to be attracted by the high-level security systems employed by the UK Atomic Energy Agency. 22-Jul-2002 The Department of Trade & Industry is to provide £5m of funding to encourage collaboration between the UK and US in biotechnology and medical research, which will help UK scientists find new partners and set up a training programme for the commercialisation of the research. 19-Jul-2002 Alcan Chemicals Europe is in negotiations to sell its Burntisland plant to the Rider Group, and a deal is expected by the end of September. 19-Jul-2002 Onyx Scientific has raised about £2m to open new pharmaceutical sample laboratories in Sunderland, and will create about 50 jobs over the next 18 months. 11-Jul-2002 Elan, the pharmaceuticals group, is planning to raise £600m from the sale of various assets over the next 18 months, including equity holdings and products, in order to ease fears over its debt position. 10-Jul-2002 CellFactors is planning to raise £8m in a share offer to fund the development of its Skeletex bone repair product and its neural cell therapy product. 10-Jul-2002 Baxter Healthcare is to shed 70 of the 650 jobs at its intravenous products manufacturing plant in Thetford, Norfolk. 09-Jul-2002 Oxagen is to shed more than 20 jobs in its Oxfordshire-based biotechnology business, and has dropped plans for a flotation. 08-Jul-2002 British Biotech is seeking acquisitions and research collaborations in Europe and North America in order to expand its portfolio of drugs. 08-Jul-2002 Charterhouse Therapeutics is looking to raise £15m to set up a laboratory in the Oxford area to develop a new class of drugs to treat viruses. 04-Jul-2002 ReNeuron is looking to merge its biotechnology business with a US group, in order to gain access to funding and provide a US company with access to the UK's more relaxed environment for stem cell research. 01-Jul-2002 Avecia is seeking planning permission for the £1.9m extension of its pharmaceutical laboratory facilities in Billingham. 27-Jun-2002 Oxford Glycosciences is looking into the possibility of merging with a rival biotechnology company, having failed to win US regulatory approval for its Vevesca treatment for Gaucher's disease. 25-Jun-2002 BioVex, the Oxford-based biotechnology company, is planning to raise up to £20m in a funding round. 24-Jun-2002 Croda International is to sell or close chemical plants in Market Harborough, Knottingley, Hull and Leek, putting 150 jobs at risk, and 40 jobs will be lost when production is moved from the Westbrook Lanolin site in Bradford to Rawcliffe Bridge. 21-Jun-2002 Unilever is to shed 190 jobs at its Home & Personal Care research and development laboratory in Wirral. 20-Jun-2002 Procter & Gamble is in negotiations with two US companies - EDS and Affiliated Computer Services - to outsource its Global Business Services department, which would involve the transfer of 750 staff at the Cobalt Business Park on North Tyneside. 19-Jun-2002 CAB International, the environmental and medical research company, is considering plans to consolidate its operations onto a single site in Wallingford, which would involve the relocation of 100 staff from Surrey. 18-Jun-2002 ICI is to sell its remaining 30% stake in the Huntsman International bulk chemicals business to CSFB Global Opportunities Partners for £291m. 18-Jun-2002 Coopervision is planning to relocate its contact lens manufacturing operations from Farnborough to Southampton over the next 14 months, as part of a phased closure that will result in job losses at Farnborough. 12-Jun-2002 Veterinary Laboratories Agency is planning to revamp its research and development facilities in Weybridge at a cost of £40m. 10-Jun-2002 Elan is planning to restructure its pharmaceuticals business by reducing its locations from 32 to about 16, withdrawing from some its 55 research joint ventures, and concentrating on neurology and pain management products. 10-Jun-2002 Prolifix of Abingdon has linked up with TopoTarget of Denmark to form a specialist anti-cancer group. 05-Jun-2002 The Medical Research Council has awarded a £9m contract to Shepherd to build a new laboratory and research centre in Oxford. 30-May-2002 Provalis is looking to sell or close its vaccines business, in order to reduce research and development costs by £2m a year. 24-May-2002 Cambridge Antibody Technology is planning to increase research spending by 60%, raise headcount from 270 to 300 and consolidate its Cambridgeshire operations onto one site. 21-May-2002 Numark, the independent pharmacy group with 1,500 members, is in merger talks with Middlesex-based rival Nucare, and is also planning to transform itself into an unlisted company this summer. 20-May-2002 Falkirk Council has approved plans from Feralco to relocate its aluminium sulphate plant and 10 staff from Glasgow to Grangemouth Docks. 17-May-2002 Skyepharma has raised £15m from the sale of the European distribution rights of the Solaraze skin treatment to Shire Pharmaceuticals, and has also announced a £25m investment from Kowa of Japan. 14-May-2002 Syngenta has announced plans to close its crop protection chemicals plant in Grimsby over the next three years, with the loss of 150 jobs. 10-May-2002 PPG is to close a coatings plant in Birmingham with the loss of 80 jobs, as part of a global cost-cutting programme. 03-May-2002 Huntsman is to invest £20m in the overhaul of its olefins cracker on Teesside over the next few months. 30-Apr-2002 ML Laboratories is planning to float the manufacturing operations of its Cobra Therapeutics division, in order to raise a few million pounds. 30-Apr-2002 Distillex is planning to relocate its North Shields chemical plant following a recent fire, which will affect 12 staff. 29-Apr-2002 BioProjects International, the provider of funding to biotech companies, is planning to raise about £4m in a flotation on Aim. 29-Apr-2002 Wellcome Trust and the government are to provide £45m of funding to the BioBank UK project to establish links between genes and disease, and bids will be invited to set up a national co-ordinating centre and five regional centres. 29-Apr-2002 Tripos Receptor Research is to set up a £16m drug research laboratory in Bude, Cornwall, with the creation of up to 146 jobs. 26-Apr-2002 Axis-Shield has raised £8.3m in a share placing to fund the expansion of its medical diagnostics business. 26-Apr-2002 Biotrace International has acquired the hygiene testing assets of Konica Corporation of Japan for £0.2m, in order to expand its industrial and medical microbiology products business across the Asia Pacific region. 24-Apr-2002 Syngenta is to shed 130 of the 780 jobs at its crop protection chemicals plant in Huddersfield. 23-Apr-2002 Ciba Specialty Chemicals is to shed 70 of the 400 jobs at its Clayton plant in Manchester, in order to transfer production of some textile dyes to Asia, and is also considering plans to redevelop parts of the 57-acre. 16-Apr-2002 Avon is to close its cosmetics factory in Northampton with the loss of 465 jobs, in order to transfer production to Poland. 15-Apr-2002 Eastman Chemical is to close its Altovar varnishes factory in Banbury later this year with the loss of 18 jobs, in order to transfer production to Belgium. 12-Apr-2002 BOC is to invest £70m in an industrial gases joint venture in Nanjing, China, with Sinopec YPC, which will involve the acquisition of three existing air separation units and the construction of a new facility. 10-Apr-2002 Ark Therapeutics is planning to raise £40m in a flotation, and its first biotechnology-based products are expected to be launched in 2004. 08-Apr-2002 GlaxoSmithKline is donating £750,000 to the Teesdale Enterprise Fund, which aims to create 150 jobs in County Durham by helping new and expanding businesses. 04-Apr-2002 GlaxoSmithKline has warned that more than 200 staff may face compulsory redundancy at its Barnard Castle plant in County Durham, while a further 180 have accepted voluntary redundancy. 29-Mar-2002 Galen has bought two dermatology products - Moisturel and Duricef - from Bristol-Myers Squibb of the US for £28m. 29-Mar-2002 Goldshield is to acquire the UK and Irish sales, marketing and distribution rights to 10 pharmaceutical products from Wyeth for £4.8m. 27-Mar-2002 PPL Therapeutics is looking to raise up to £20m from the spin-out of its xenotransplantation and stem cell research operations, in order to fund the commercial development of other projects. 26-Mar-2002 Alliance UniChem is considering plans to expand its pharmaceuticals distribution and retailing business into Turkey and eastern Europe, as part of a strategy to become Europe's market leader. 21-Mar-2002 Albion Chemicals is to close its sulphuric acid production plant in Sutton, Merseyside, in April with the loss of 60 jobs. 19-Mar-2002 Biocompatibles has agreed to sell its cardiovascular stent business to US partner Abbott Laboratories for £164m, leaving Biocompatibles as a cash shell. 19-Mar-2002 Mobious Genomics is considering plans to set up a £45m 150,000 sq ft laboratory at Exeter University's Innovation Centre to help major pharmaceutical companies process complex data about human genes, which could lead to the creation of up to 450 jobs. 18-Mar-2002 Oxford Glycosciences is to collaborate with BioInvent of Sweden to develop new therapeutic antibodies over the next three years, and will invest £3.5m in BioInvent shares. 15-Mar-2002 Skyepharma has acquired the remaining 60% of RTP Pharma of Canada for £14m, and has raised £20m of development funding from Paul Capital Royalty Acquisition Fund. 14-Mar-2002 Pennine Healthcare is to set up a new headquarters for its health products business at the City Gate development in Derby in June, which will involve the relocation of up to 250 staff from its two existing sites nearby. 13-Mar-2002 Amersham is to take full control of its life sciences division by paying £704m for the 45% stake held by Pharmacia, and has dropped plans for a partial flotation of the business. 13-Mar-2002 Bespak has started work on the £20m extension of its inhalers factory in King's Lynn, which will secure the future of 600 jobs. 11-Mar-2002 ClinPhone, the supplier of pharmaceutical testing services, is planning a £100m flotation, and the proceeds will be used to make acquisitions and open offices in continental Europe and the Far East. 11-Mar-2002 Procter & Gamble is to close the recently-acquired Clairol beauty products factory in Cramlington with the loss of 60 jobs, while more than 100 jobs will be relocated to its plant at nearby Seaton Delaval. 08-Mar-2002 Provalis is raising £10m in a share placing to fund the development of products based on derivatives of its Glycosal monitor for diabetes. 08-Mar-2002 Wellbeing is planning to raise £1.2m in a flotation on Ofex to expand its health screening kits business. 05-Mar-2002 Sanofi-Synthelabo is planning to build a new £50m pharmaceuticals plant at its Fawdon site on Tyneside by 2004, but up to 100 jobs will be lost when the production of generic products is transferred to Eastern Europe. 28-Feb-2002 Avecia has confirmed plans to build a £70m biological medicines plant in Billingham by 2005, creating 300 jobs at what will be the world's largest pharmaceutical microbial fermentation facility. 28-Feb-2002 Celltech is investing £5m at its pharmaceuticals factory in Ashton-under-Lyne, which will involve upgrading its sterile production capabilities. 25-Feb-2002 The University of York is seeking permission to build a new £11m chemistry department at its Heslington site by 2004. 25-Feb-2002 PCI Services is planning a £10m expansion at its pharmaceutical packaging business in Corby, with the creation of 200 jobs over the next two years. 22-Feb-2002 Dow Chemicals is to shed 50 of the 210 jobs at its recently-acquired Haltermann Custom Processing plants in Middlesbrough and Billingham. 19-Feb-2002 MMI has announced plans to transform the former Roche drug discovery centre in Welwyn Garden City into an incubator for start-up companies in the biotechnology sector. 19-Feb-2002 Microscience has raised £25m to fund clinical trials of five new vaccines currently under development. 18-Feb-2002 Paterson Zochonis is to change its name to PZ Cussons to associate more closely with its soap brands, and has also announced plans to seek more acquisitions and joint ventures. 13-Feb-2002 Arrow Therapeutics has raised £7m to fund both acquisitions and its research into new types of antibiotics. 11-Feb-2002 Chemilines, the pharmaceutical distributor, is setting up a new 70,000 sq ft headquarters at Alperton Lane near Wembley, at a cost of £7.2m. 04-Feb-2002 ICI has put its Synetix catalyst business up for sale, which employs 400 people at Billingham and a further 400 worldwide. 01-Feb-2002 TotalFinaElf is to expand its Cray Valley resins and paint products factory in Stallingborough later this year with the creation of up to 100 jobs, but its Caerphilly factory will close with the loss of about half the 200-strong workforce. 01-Feb-2002 Gendel has raised £2m of venture capital to fund the development of a new process for the controlled delivery of drugs using red blood cells. 01-Feb-2002 Perlos is to start producing products for the pharmaceutical sector at its Rainton Bridge factories near Houghton-le-Spring, following a fall in demand for plastic phone casings. 30-Jan-2002 York Bioanalytical Solutions is to relocate its York-based bioscience laboratory to a new £1m site in Poppleton in May, with the creation of 32 new jobs. 30-Jan-2002 ML Laboratories is planning to sell off its non-core activities - including the Innovata Biomed inhaler business and the DNA production division of its Cobra subsidiary - in order to focus on cancer treatment and pain management. 30-Jan-2002 Alcan Chemicals is looking to sell its aluminium-based chemicals plant in Fife, which employs 385 people, and a management buy-out is said to be a possibility. 28-Jan-2002 Microfine Minerals is building a new 24,000 sq ft warehouse at its mica flakes factory in Derby, and expects the workforce to rise from 58 to 66. 25-Jan-2002 The University of St Andrews is linking up with Sasol of South Africa to set up a £5m laboratory this summer, employing 25 graduates to develop faster ways to make chemicals and plastics. 23-Jan-2002 Axxis International is planning to relocate its toiletries and cosmetics business from Westbury to its site in Trowbridge, with the transfer of up to 185 staff. 18-Jan-2002 CXR Biosciences has been spun out of the University of Dundee with £4m of funding to develop new drugs, and the company will move into the former Cyclacel facilities and expand staffing levels from 14 to 40 this year. 17-Jan-2002 The University of Liverpool is to set up a genetic knowledge park in partnership with the universities of Manchester and Lancaster, as part of a government scheme to establish a network of such sites in Cambridge, London, Oxford, Newcastle, Salisbury, Wales and Manchester. 17-Jan-2002 W&J Leigh is to shed 15 of the 320 jobs at its paints factory in Bolton. 16-Jan-2002 Johnson Matthey is planning to close its colours and coatings plant at Meir in Staffordshire, with the loss of 300 jobs. 16-Jan-2002 Dow Chemicals is to close its ethylene oxide derivatives plant at Wilton in March with the loss of 27 jobs. 14-Jan-2002 Amec has won a £40m contract from a BP-led consortium for the construction of a £1.9bn petrochemical plant near Shanghai in China. 11-Jan-2002 Yorkshire Group is to withdraw from commodity textile dye production in the UK with the loss of 90 jobs, and production will be concentrated at one of its Leeds sites. 09-Jan-2002 Bespak is looking to spend up to £15m on acquisitions to expand its nasal drug delivery business and develop new products. 09-Jan-2002 Avecia is seeking permission to build a new bio-pharmaceutical manufacturing facility at its site in Billingham, with the creation of about 300 jobs. 07-Jan-2002 NeuTec Pharma is looking to raise £10m in a flotation on Aim next month, in order to fund its research into treatments for antibiotic-resistant infections. 07-Jan-2002 Strakan Group has raised a further £15m in a rights issue to fund the commercial development of new treatments for bone and skin diseases. 07-Jan-2002
|